UNC-CA2-103 is a TLK2 inhibitor with a human IC50 of 18 nM, and it exhibits high selectivity over TLK1 and the vast majority of other kinases. UNC-CA2-103 can be used in research related to breast cancer, glioblastoma and gastric cancer[1].
Molecular Weight:
344.37
Purity:
99.26
CAS Number:
[3069333-33-8]
Formula:
C20H16N4O2
Target:
TLK
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted